NLRP3 and neoplasm: In contrast, ATP released from tumor cells (21) or perforin released from CD8+ cytotoxic T lymphocytes (CTLs) (66) activated NLRP3 in antigen-presenting cells (APCs) and promoted immunity against tumors.